Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of deprescribing statins and proton pump inhibitors in nursing home residents
NL-OMON46524Active, not recruiting
- Sponsor
- Zuyderland
- Start
- Apr 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Zuyderland. Primary endpoint: Decrease in PPI and statin use for the short and long term. Started Apr 2018; status: active, not recruiting.
Beyond the preview
Go deeper on NL-OMON46524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46524.